{
  "ticker": "SWT",
  "pdf_display_url": "https://www.asx.com.au/asx/v2/statistics/displayAnnouncement.do?display=pdf&idsId=02968250",
  "id": "02968250",
  "pages": 2,
  "price_sensitive": false,
  "date": "20250710",
  "time": "1551",
  "pdf_url": "https://announcements.asx.com.au/asxpdf/20250710/pdf/06lp7wk8bhpnb0.pdf",
  "summary": "### **SWTZ Fund Update \u2013 Key Takeaways**  \n\n#### **Performance & Distributions**  \n- **1-Year Grossed-Up Income Return**: 11.67% (vs. benchmark 5.18%).  \n- **Recent Monthly Return**: 0.44% (vs. benchmark 0.13%).  \n- **Distribution Yield (Gross)**: 11.67% *(includes franking credits)*.  \n- **Cash Position**: 8% of portfolio.  \n\n#### **Top Holdings (Sector Allocation Highlights)**  \n- **Financials**: 27% exposure (NAB, Westpac, ANZ, CBA driving returns).  \n- **Materials**: 15% (BHP largest holding at 6.64%).  \n- **Santos (STO)**: Added recently; benefited from takeover bid by Abu Dhabi\u2019s xReality Group (pending regulatory approval).  \n\n#### **Key Portfolio Moves & Catalysts**  \n- **Santos (STO)**: Position taken during oil price dip; potential 30% production growth via Barossa Gas & Pikka projects (WTI at ~US$60/bbl).  \n- **Challenger (CGF)**: Boosted by APRA\u2019s proposed capital framework easing for annuities (ROE upside).  \n- **Cochlear (COH)**: Bought after guidance cut; poised for growth with upcoming implant launch.  \n\n#### **Macro Context**  \n- **RBA Rate Cut**: Reduced to 3.85% (May 2025) amid inflation steady at 2.4%.  \n- **Market Caution**: Fund avoids \"overpriced assets,\" focuses on undervalued income opportunities.  \n\n*No material capital markets actions (e.g., raising, corporate action) identified.*",
  "usage": {
    "prompt_tokens": 2434,
    "completion_tokens": 372,
    "total_tokens": 2806,
    "prompt_tokens_details": null
  },
  "model": "deepseek/deepseek-chat-v3-0324:free",
  "processed_at": "2025-07-10T06:02:47.229245"
}